170 related articles for article (PubMed ID: 34337891)
1. Differential cardiotoxic electrocardiographic response to doxorubicin treatment in conscious versus anesthetized mice.
Warhol A; George SA; Obaid SN; Efimova T; Efimov IR
Physiol Rep; 2021 Aug; 9(15):e14987. PubMed ID: 34337891
[TBL] [Abstract][Full Text] [Related]
2. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
[TBL] [Abstract][Full Text] [Related]
3. Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin.
Hazari MS; Haykal-Coates N; Winsett DW; Costa DL; Farraj AK
Toxicol Sci; 2009 Jul; 110(1):224-34. PubMed ID: 19407338
[TBL] [Abstract][Full Text] [Related]
4. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
Grant MK; Seelig DM; Sharkey LC; Zordoky BN
Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect of melatonin and agomelatine on doxorubicin-induced cardiotoxicity in a rat model: an electrocardiographic, scintigraphic and biochemical study.
Aygun H; Gul SS
Bratisl Lek Listy; 2019; 120(4):249-255. PubMed ID: 31023046
[TBL] [Abstract][Full Text] [Related]
6. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice.
Rocha VC; França LS; de Araújo CF; Ng AM; de Andrade CM; Andrade AC; Santos Ede S; Borges-Silva Mda C; Macambira SG; Noronha-Dutra AA; Pontes-de-Carvalho LC
Cancer Chemother Pharmacol; 2016 Mar; 77(3):659-62. PubMed ID: 26712129
[TBL] [Abstract][Full Text] [Related]
8. Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F
Jenkins GR; Lee T; Moland CL; Vijay V; Herman EH; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC; Desai VG
Toxicol Appl Pharmacol; 2016 Nov; 310():159-174. PubMed ID: 27644598
[TBL] [Abstract][Full Text] [Related]
9. Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.
Zhang W; Deng J; Sunkara M; Morris AJ; Wang C; St Clair D; Vore M
J Pharmacol Exp Ther; 2015 Nov; 355(2):280-7. PubMed ID: 26354995
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-9 aggravates doxorubicin-induced cardiotoxicity by promoting inflammation and apoptosis in mice.
Ye D; Wang Z; Xu Y; Ye J; Wang M; Liu J; Zhang J; Zhao M; Chen J; Wan J
Life Sci; 2020 Aug; 255():117844. PubMed ID: 32464124
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity.
Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W
J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266
[TBL] [Abstract][Full Text] [Related]
12. Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway.
Liu Y; Zhou L; Du B; Liu Y; Xing J; Guo S; Li L; Chen H
Oxid Med Cell Longev; 2021; 2021():9984330. PubMed ID: 34422218
[TBL] [Abstract][Full Text] [Related]
13. Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer.
Lee KJ; Wright G; Bryant H; Wiggins LA; Dal Zotto VL; Schuler M; Malozzi C; Cohen MV; Gassman NR
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299059
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-induced cardiotoxicity involves IFNγ-mediated metabolic reprogramming in cardiomyocytes.
Ni C; Ma P; Wang R; Lou X; Liu X; Qin Y; Xue R; Blasig I; Erben U; Qin Z
J Pathol; 2019 Mar; 247(3):320-332. PubMed ID: 30426505
[TBL] [Abstract][Full Text] [Related]
15. Genotoxicity, nitric oxide level modulation and cardio-protective potential of Kalanchoe Integra Var. Crenata (Andr.) Cuf Leaves in murine models.
Asiedu-Gyekye IJ; Arhin E; Arthur SA; N'guessan BB; Amponsah SK
J Ethnopharmacol; 2022 Jan; 283():114640. PubMed ID: 34606947
[TBL] [Abstract][Full Text] [Related]
16. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.
Hamlin RL; Kijtawornrat A; Keene BW; Hamlin DM
Toxicol Sci; 2003 Dec; 76(2):437-42. PubMed ID: 14600288
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
Ma ZG; Kong CY; Wu HM; Song P; Zhang X; Yuan YP; Deng W; Tang QZ
Theranostics; 2020; 10(24):11013-11025. PubMed ID: 33042267
[No Abstract] [Full Text] [Related]
18. Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p.
Wang X; Cheng Z; Xu J; Feng M; Zhang H; Zhang L; Qian L
Life Sci; 2021 Jan; 265():118788. PubMed ID: 33245966
[TBL] [Abstract][Full Text] [Related]
19. Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway.
Liang L; Tu Y; Lu J; Wang P; Guo Z; Wang Q; Guo K; Lan R; Li H; Liu P
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028181
[TBL] [Abstract][Full Text] [Related]
20. sFRP1 has a biphasic effect on doxorubicin-induced cardiotoxicity in a cellular location-dependent manner in NRCMs and Rats.
Hu Y; Guo Z; Lu J; Wang P; Sun S; Zhang Y; Li J; Zheng Q; Guo K; Wang J; Jiang J; Liu P
Arch Toxicol; 2019 Feb; 93(2):533-546. PubMed ID: 30377735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
